Recombinant Human SLC16A1 Protein，His & SUMO

SLC16A1, also known as monocarboxylate transporter 1 (MCT1), is a crucial membrane protein that facilitates the transport of monocarboxylates, such as lactate, pyruvate, and other metabolites, across cell membranes. Its role in cellular metabolism is vital for various physiological processes, including energy production, pH regulation, and cellular signaling. Recent research has highlighted the significance of SLC16A1 in multiple diseases, including cancers, where altered expression of this transporter contributes to the Warburg effect, enabling tumor cells to thrive in low-oxygen environments by favoring glycolysis and lactate production. Understanding the structural and functional characteristics of SLC16A1 through the study of recombinant protein is essential for elucidating its mechanisms of action and regulatory pathways. The development of recombinant SLC16A1 can pave the way for high-throughput screening of potential therapeutics, aimed at modulating its function to restore normal metabolic processes or inhibit tumor growth. Furthermore, investigating the interactions between SLC16A1 and its substrates can provide insights into its role in metabolic disorders and facilitate the identification of novel biomarkers for disease diagnosis and progression. The ongoing research into SLC16A1 not only enhances our understanding of its fundamental biological roles but also holds significant potential for therapeutic applications in metabolic diseases and cancer treatment.